Editorial
 108 DRUGS MORE UNDER DPCO   
 Wednesday, July 23, 2014 
 National Pharmaceutical Pricing Authority, early this month, brought 108 essential drugs more under the ambit of Drug Price Control Order, 2013 in addition to 348 drugs already under price control. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Perrigo's testosterone gel 1.0% receives US FDA AB therapeutic equivalent rating
17:00  [IST]US FDA alerts healthcare professionals on recall of non-expired sterile drugs from Unique Pharma
16:00  [IST]Common gene variants account for most genetic risk for autism: NIH study
15:00  [IST]GSK submits regulatory application to EMA for malaria vaccine candidate RTS,S
14:00  [IST]CMDh endorses suspension of methadone oral solutions containing high molecular weight povidone
13:00  [IST]Endo completes acquisition of Mexican-based specialty pharma company Somar
more news >>
TOP NEWS
08:00  [IST]KDPMA upset over price cuts of 108 drugs; insists govt to take industry into confidence
08:00  [IST]SRL Diagnostics to launch Echosens Fibro Meter Virus Test for patients infected with viral hepatitis
08:00  [IST]WHO to organise programme on pharma procurement procedures at Copenhagen from Sept 22-25
08:00  [IST]Pharma sector benefits from ‘Virtual Man’ as it can clinical trials by 40%: Prof PV Mallya
08:00  [IST]Diabetacare releases novel app ‘Snap a Meal' to help diabetic patients to manage weight, blood sugar levels
08:00  [IST]NPPA's recent price control order on 108 non-scheduled formulations to cover all companies
more news >>
YESTERDAY'S NEWS
18:00  [IST]US FDA approves Targiniq ER to treat pain
17:20  [IST]Strides Arcolab Q1 revenue up by 14% to Rs. 260 crore
17:00  [IST]Taiho Pharma to invest US$ 30 mn in Remiges BioPharma Fund
16:30  [IST]Fortis Healthcare launches cancer institute at Mohali, Punjab
16:00  [IST]US FDA approves Gilead's Zydelig to treat relapsed chronic lymphocytic leukaemia
15:45  [IST]Eli Lilly' net earnings declines by 39% in Q2
more news >>
INTERVIEW  
There is light at the end of the tunnel for the Indian clinical trial industry
Global clinical research organizations, leading international research centers and the bio pharma abroad are keen to conduct the human studies on the Indian patient population.
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent move to increase the number of drugs covered under the national list of essential medicines (NLEM) justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |